Suppr超能文献

硫代磷酸酯反义寡核苷酸诱导核小体的形成。

Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.

作者信息

Lorenz P, Baker B F, Bennett C F, Spector D L

机构信息

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

出版信息

Mol Biol Cell. 1998 May;9(5):1007-23. doi: 10.1091/mbc.9.5.1007.

Abstract

Antisense oligonucleotides are powerful tools for the in vivo regulation of gene expression. We have characterized the intracellular distribution of fluorescently tagged phosphorothioate oligodeoxynucleotides (PS-ONs) at high resolution under conditions in which PS-ONs have the potential to display antisense activity. Under these conditions PS-ONs predominantly localized to the cell nucleus where they accumulated in 20-30 bright spherical foci designated phosphorothioate bodies (PS bodies), which were set against a diffuse nucleoplasmic population excluding nucleoli. PS bodies are nuclear structures that formed in cells after PS-ON delivery by transfection agents or microinjection but were observed irrespectively of antisense activity or sequence. Ultrastructurally, PS bodies corresponded to electron-dense structures of 150-300 nm diameter and resembled nuclear bodies that were found with lower frequency in cells lacking PS-ONs. The environment of a living cell was required for the de novo formation of PS bodies, which occurred within minutes after the introduction of PS-ONs. PS bodies were stable entities that underwent noticeable reorganization only during mitosis. Upon exit from mitosis, PS bodies were assembled de novo from diffuse PS-ON pools in the daughter nuclei. In situ fractionation demonstrated an association of PS-ONs with the nuclear matrix. Taken together, our data provide evidence for the formation of a nuclear body in cells after introduction of phosphorothioate oligodeoxynucleotides.

摘要

反义寡核苷酸是体内调节基因表达的有力工具。我们在硫代磷酸酯寡脱氧核苷酸(PS-ONs)具有显示反义活性潜力的条件下,以高分辨率表征了荧光标记的硫代磷酸酯寡脱氧核苷酸(PS-ONs)的细胞内分布。在这些条件下,PS-ONs主要定位于细胞核,它们在20 - 30个明亮的球形病灶中积累,这些病灶被称为硫代磷酸酯小体(PS小体),与排除核仁的弥漫性核质群体形成对比。PS小体是在通过转染试剂或显微注射递送PS-ONs后在细胞中形成的核结构,但无论反义活性或序列如何均可观察到。在超微结构上,PS小体对应于直径为150 - 300 nm的电子致密结构,类似于在缺乏PS-ONs的细胞中以较低频率发现的核小体。PS小体的从头形成需要活细胞环境,这在引入PS-ONs后几分钟内就会发生。PS小体是稳定的实体,仅在有丝分裂期间经历明显的重组。有丝分裂结束后,PS小体从子细胞核中的弥漫性PS-ON池重新组装而成。原位分级分离表明PS-ONs与核基质有关。综上所述,我们的数据为引入硫代磷酸酯寡脱氧核苷酸后细胞中形成核小体提供了证据。

相似文献

1
Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.
Mol Biol Cell. 1998 May;9(5):1007-23. doi: 10.1091/mbc.9.5.1007.
2
Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
Nucleic Acid Ther. 2019 Dec;29(6):343-358. doi: 10.1089/nat.2019.0806. Epub 2019 Aug 20.
6
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective.
Nucleic Acid Ther. 2021 Apr;31(2):126-144. doi: 10.1089/nat.2020.0923. Epub 2021 Feb 2.
7
Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation.
Antimicrob Agents Chemother. 2006 Apr;50(4):1393-401. doi: 10.1128/AAC.50.4.1393-1401.2006.
9
Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro Cytotoxicity.
Nucleic Acid Ther. 2017 Feb;27(1):11-22. doi: 10.1089/nat.2016.0639. Epub 2016 Dec 6.

引用本文的文献

1
Unveiling sequence-agnostic mixed-chemical modification patterns for splice-switching oligonucleotides using the NATURA platform.
Mol Ther Nucleic Acids. 2025 Jan 7;36(1):102422. doi: 10.1016/j.omtn.2024.102422. eCollection 2025 Mar 11.
2
Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids.
Molecules. 2024 Dec 19;29(24):5997. doi: 10.3390/molecules29245997.
3
High-resolution visualisation of antisense oligonucleotide release from polymers in cells.
Chem Sci. 2024 Aug 28;15(38):15690-7. doi: 10.1039/d3sc06773d.
4
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.
Sci Rep. 2021 Feb 25;11(1):4722. doi: 10.1038/s41598-021-84194-w.
5
Recent Advances in the Molecular Beacon Technology for Live-Cell Single-Molecule Imaging.
iScience. 2020 Nov 13;23(12):101801. doi: 10.1016/j.isci.2020.101801. eCollection 2020 Dec 18.
7
Phosphorothioate modified oligonucleotide-protein interactions.
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. doi: 10.1093/nar/gkaa299.
8
Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.
Yonsei Med J. 2020 Apr;61(4):273-283. doi: 10.3349/ymj.2020.61.4.273.
10
Nuclear and Cytoplasmatic Quantification of Unconjugated, Label-Free Locked Nucleic Acid Oligonucleotides.
Nucleic Acid Ther. 2020 Feb;30(1):4-13. doi: 10.1089/nat.2019.0810. Epub 2019 Oct 16.

本文引用的文献

1
Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Nat Biotechnol. 1996 Jul;14(7):840-4. doi: 10.1038/nbt0796-840.
3
Advances in understanding the pharmacological properties of antisense oligonucleotides.
Adv Pharmacol. 1997;40:1-49. doi: 10.1016/s1054-3589(08)60136-2.
6
Major internal nuclear matrix proteins are common to different human cell types.
J Cell Biochem. 1997 Apr;65(1):42-52. doi: 10.1002/(sici)1097-4644(199704)65:1<42::aid-jcb5>3.0.co;2-z.
8
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma.
Lancet. 1997 Apr 19;349(9059):1137-41. doi: 10.1016/s0140-6736(96)11103-x.
10
Antisense technology and prospects for therapy of viral infections and cancer.
Mol Med Today. 1997 Jan;3(1):31-8. doi: 10.1016/S1357-4310(96)10053-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验